Tower Research Capital (TRC)’s CollPlant Biotechnologies CLGN Stock Holding History

Tower Research Capital (TRC)’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Hold	0	–	-$5	–	5734
2024 Q2	–	Hold	0	–	–	–	5615
2022 Q3	–	Sell	-89	Closed	-$7K	–	6100
2022 Q2	$7K	Buy	+89	New	+$8.18K	﹤0.01%	4770
2021 Q4	–	Sell	-9	Closed	-$1K	–	6172
2021 Q3	$1K	Sell	9 -51	-85%	-$9.16K	﹤0.01%	5437
2021 Q2	$13K	Buy	+60	New	+$9.59K	﹤0.01%	4215

Other funds holding CLGN

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tower Research Capital (TRC)'s CLGN Position: Q3 2024 in Review

Tower Research Capital (TRC) held its CollPlant Biotechnologies (CLGN) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5734.

Tower Research Capital (TRC) first reported a position in CLGN in Q2 2021 and has held it in 3 quarters since. The position peaked at $13K in Q2 2021. 12 funds tracked by Wall St. Rank hold CLGN as of Q3 2024.

Tower Research Capital (TRC) held 0 shares of CollPlant Biotechnologies worth $0 as of Q3 2024.
Tower Research Capital (TRC) left its CollPlant Biotechnologies share count unchanged in Q3 2024.
CollPlant Biotechnologies made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2024, its #5734 holding.
Tower Research Capital (TRC) first reported a position in CollPlant Biotechnologies in Q2 2021 and has held it in 3 quarters since.
Tower Research Capital (TRC)'s CollPlant Biotechnologies position peaked at $13K in Q2 2021.
12 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.